Press Releases
Pharmspective introduces PolicyView: A Specialty Drug Medical Policy Aggregator
FOR IMMEDIATE RELEASE
New York, NY, July 15, 2013 – Pharmspective, LLC today announced the release of its’ newest Market Access tool-PolicyView™, a PC and iPad application that houses a comprehensive library of reimbursement policies for Specialty Drugs across leading payers in the U.S. Pharmspective, LLC creates Data Visualization tools that simplify the understanding of key insights derived from its proprietary primary and secondary market research on Market Access for Specialty Therapeutics.
PolicyView™ characterizes the key criteria for authorization and utilization of therapies in Autoimmune disease and Oncology. PolicyView™ has a user-friendly interface that allows for individual and comparative assessment of payer utilization management criteria for specialty drugs and the added capability to search and extract portions of their medical policies, based on keywords.
“The research and planning that we undertook to build PolicyView™ was done with a singular focus on comprehensively and accurately characterizing the access and reimbursement landscape for Specialty Drugs,” stated Stephen Reid, Managing Partner. “PolicyView™ will prove invaluable to pharmaceutical and biotech Market Access teams who are keenly interested in understanding how these medical policies are influencing treatment decisions for Specialty Therapeutics (including Biologics).”
PolicyView™ will allow subscribers to:
- Track trends in payer coverage policies by therapeutic category over time
- Quickly and efficiently source medical policy data without cumbersome searching across insurer websites
- Develop geographic insights into the market access landscape for specific disease areas
Pharmspective’s data visualization tools provide state-of-the-art user interfaces that provide a detailed look at the market access landscape from a wide range of perspectives. The company’s first market access application, ClearView™, is a knowledge management platform supporting training, research, and strategy development for the Affordable Care Act.